Isolate Data
| Patient | Isolate | Region | Year | Species | Subtype | Source | Clone Method |
| AAC-DDC | AACPO | U.S. | 1990 | HIV1 | B | PBMC | MMC |
Treatment History
| Order | Regimen | Weeks |
| 1 | DDC | 80 |
RT Sequence
| NRTIMajorDRMs | NRTIMinorDRMs | NNRTIMajorDRMs | NNRTIMinorDRMs | Polys | UnusualMuts |
| T69D | R83K, I135V, T165I, A272P |
| >AACPO| 16 | codons 63-279 | clone 16 IKKKDSTKWRKLVDFRELNKKTQDFWEVQLGIPHPAGLKKKKSVTVLDVGDAYFSVPLDK DFRKYTAFTIPSVNNETPGIRYQYNVLPQGWKGSPAIFQSSMTKILEPFRKQNPDIVIYQ YMDDLYVGSDLEIGQHRTKIEELRQHLLRWGFTTPDKKHQKEPPFLWMGYELHPDKWTVQ PIVLPEKDSWTVNDIQKLVGKLNWASQIYPGIKVKQL >AACPO| 21 | codons 63-279 | clone 21 IKKKDSDKWRKLVDFRELNKKTQDFWEVQLGIPHPAGLKKKKSVTVLDVGDAYFSVPLDK DFRKYTAFTIPSVNNEIPGIRYQYNVLPQGWKGSPAIFQSSMIKILEPFRKQNPDIVIYQ YMDDLYVGSDLEIGQHRTKIEELRQHLLRWGFTTPDKEHQKEPPFLWMGYELHPDKWTVQ PIVLPEKDSWTVNDIQKLVGKLNWASQIYPGIKVKQL >AACPO| 5 | codons 63-279 | clone 5 IKKKDSDKWRKLVDFRELNKKTQDFWEVQLGIPHPAGLKKKKSVTVLDVGDAYFSVPLDK DFRKYTAFTIPSVNNETPGIRYQYNVLPQGWKGSPAIFQSSMTKILEPFRKQNPDIVIYQ YMDDLYVGSDLEIGQHRTKIEELRQHLLRWGFTTPDKKHQKEPPFLWMGYELHPDKWTVQ PIVLPEKDSWTVNDIQKLVGKLNWASQIYPGIKVRQL >AACPO| 47 | codons 63-279 | clone 47 IKKKDSDKWRKLVDFRELNKKTQDFWEVQLGIPHPAGLKKKKSVTVLDVGDAYFSVPLDK DFRKYTAFTIPSINNETPGIRYQYNVLPQGWKGSPAIFQSSMIKILEPFRKQNPDIVIYQ YMDDLYVGSDLEIGQHRTKIEELRQHLLRWGFTTPDKKHQKEPPFLWMGYELHPDKWTVQ PIVLPEKDSWTVNDIQKLVGKLNWASQIYPGIKVKQL >AACPO| 41 | codons 63-279 | clone 41 IKKKDSDKWRKLVDFRELNKKTQDFWEVQLGIPHPAGLKKKKSVTVLDVGDAYFSVPLDK DFRKYTAFTIPSVNNETPGIRYQYNVLPQGWKGSPAIFQSSMIKILEPFRKQNPDIVIYQ YMDDLYVGSDLEIGQHRTKIEELRQHLLRWGFTTPDKKHQKEPPFLWMGYELHPDKWTVQ PIVLPEKDSWTVNDIQKLVGKLNWASQIYPGIKVKQL >AACPO| 32 | codons 63-279 | clone 32 IKKKDSDKWRKLVDFRELNKKTQDFWEVQLGIPHPAGLKKKKSVTVLDVGDAYFSVPLDK DFRKYTAFTIPSINNETPGIRYQYNVLPQGWKGSPAIFQSSMTKILEPFRKQNPDIVIYQ YMDDLYVGSDLEIGQHRTKIEELRQHLLKWGFTTPDKKHQKEPPFLWMGYELHPDKWTVQ PIVLPEKDSWTVNDIQKLVGKLNWASQIYPGIKVKQL >AACPO| 30 | codons 63-279 | clone 30 IKKKDSDKWRKLVDFRELNKKTQDFWEVQLGIPHPAGLKKKKSVTVLDVGDAYFSVPLDE DFRKYTAFTIPSINNETPGIRYQYNVLPQGWKGSPAIFQSSMTKILEPFRKQNPDIVIYQ YVDDLYVGSDLEIGQHRTKIEELRQHLLRWGFTTPDKKHQKEPPFLWMGYELHPDKWTVQ PIVLPEKDSWTVNDIQKLVGKLNWASQIYPGIKVKQL >AACPO| 25 | codons 63-279 | clone 25 IKKKDSDKWRKLVDFRELNKKTQDFWEVQLGIPHPAGLKKKKSVTVLDVGDAYFSVPLDK DFRKYTAFTIPSVNNETPGIRYQYNVLPQGWKGSPAIFQSSMIKILEPFRKQNPDIVIYQ YMDDLYVGSDLEIGQHRTKIEELRQHLLRWGFTTPDKKHQKEPPFLWMGYELHPDKWTVQ PIALPKKDSWTVNDIQKLVGKLNWASQIYPGIKVKQL >AACPO| 12 | codons 63-279 | clone 12 IKKKDSDKWRKLVDFRELNKKTQDFWEVQLGIPHPAGLKKKKSVTVLDVGDAYFSVPLDK DFRKYTAFTIPSVNNETPGIRYQYNVLPQGWKGSPAIFQSSMIKILEPFRKQNPDIVIYQ YMDDLYVGSDLEIGQHRTKIEELRQHLLRWGFTTPDKKHQKEPPFLWMGYELHPDKWTVQ PIVLPEKDSWTVNDIQKLVGKLNWASQIYPGIKVKQL >AACPO| 28 | codons 63-279 | clone 28 IKKKDSDKWRKLVDFRELNKKTQDFWEVQLGIPHPAGLKKKKSVTVLDVGDAYFSVPLDK DFRKYTAFTIPSVNNEIPGIRYQYNVLPQGWKGSPAIFQSSMIKILEPFRKQNPDIVIYQ YMDDLYVGSDLEIGQHRTKIEELRQHLLRWGFTTPDKEHQKEPPFLWMGYELHPDKWTVQ PIVLPEKDSWTVNDIQKLVGKLNWASQIYPGIKVKQL >AACPO| 18 | codons 63-279 | clone 18 IKKKDSDKWRKLVDFRELNKKTQDFWEVQLGIPHPAGLKKKKSVTVLDVGDAYFSVPLDE DFRKYTAFTIPSVNNETPGIRYQYNVLPQGWKGSPAIFQSTMTKILEPFRKQNPDIVIYQ YMDDLYVGSDLEIGQHRTKIEELRQHLLRWGFTTPDKKHQKEPPFLWMGYELHPDKWTVQ PIVLPEKDSWTVNDI*KLVGKLNWASQIYPGIKVKQL >AACPO| codons 63-279 IKKKDSDKWRKLVDFRELNKKTQDFWEVQLGIPHPAGLKKKKSVTVLDVGDAYFSVPLDK DFRKYTAFTIPSVNNETPGIRYQYNVLPQGWKGSPAIFQSSMIKILEPFRKQNPDIVIYQ YMDDLYVGSDLEIGQHRTKIEELRQHLLRWGFTTPDKKHQKEPPFLWMGYELHPDKWTVQ PIVLPEKDSWTVNDIQKLVGKLNWASQIYPGIKVKQL |
References
| Author | Title | Citation |
| Fitzgibbon, JE | Human immunodeficiency virus type 1 pol gene mutations which cause decreased susceptibility to 2',3'-dideoxycytidine. | AAC, 1992 |
| Rhee, SY | HIV-1 Protease and Reverse Transcriptase Mutations: Correlations with Antiretroviral Therapy in Subtype B Isolates and Implications for Drug-Resistance Surveillance. | J Infect Dis, 2005 |